NEW YORK (GenomeWeb) – Nanosphere today priced the public offering of 40 million shares of its common stock at $.50 per share.

The company also announced after the close of the market on Tuesday preliminary revenues of $3.7 million for the third quarter, said that its shares will move to the Nasdaq Capital Market from the Nasdaq Global Market, and said that it had terminated a stock purchase agreement forged earlier this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.